Hypoglycemic activity of aqueous seed extract of<i>Hunteria umbellata</i>in normal and streptozotocin-induced diabetic rats

Abstract

The present study evaluated the aqueous seed extract of Hunteria umbellata K. Schum (Apocynaceae) for hypoglycemic activity in rats. Diabetes was induced by a single dose of streptozotocin (50 mg/kg i.p.). Daily doses of 400, 800, and 1000 mg/kg of extract were orally administered to fasted normal and diabetic rats. Blood glucose levels were monitored after 0, 2, 4, 8, 12 h and on day 14 post treatment. Liver glycogen levels were also estimated on day 14. In normal rats, only 400 mg/kg of the extract produced a significant reduction in blood glucose at the 4 h (P < 0.05) which was 22.15 ± 4.88%. In diabetic rats, the extract, 400, 800 mg/kg, caused significant reduction (P < 0.01), 51.87% ± 5.79% and 43.47% ± 8.06% respectively, with maximum effect at 8 h. This reduction in blood glucose was greater than that of glibenclamide (31.03% ± 8.86%). Diabetic rats administered with 400 mg/kg extract produced a significant reduction (P < 0.01) on day 14 (43.60% ± 8.10%). Liver glycogen levels were significantly increased (P < 0.05) in diabetic rats administered with doses of 400 and 800 mg/kg extracts and these were comparable to glibenclamide. Acute toxicity data showed no mortality in mice up to 17.5 g/kg. We conclude that the extract possesses marked hypoglycemic effects in diabetic rats possibly through increased glycogenesis, thus justifying its use in herbal medicine for the treatment of diabetes.